Alcon Inc. (LON:0A0D)

London flag London · Delayed Price · Currency is GBP · Price in CHF
79.66
+0.13 (0.17%)
At close: May 12, 2025
8.24%
Market Cap 35.59B
Revenue (ttm) 7.92B
Net Income (ttm) 813.15M
Shares Out n/a
EPS (ttm) 1.64
PE Ratio 43.77
Forward PE 29.12
Dividend 0.21 (0.26%)
Ex-Dividend Date May 13, 2025
Volume 163,597
Average Volume 84,038
Open 79.95
Previous Close 79.53
Day's Range 79.04 - 80.81
52-Week Range 55.26 - 75.36
Beta 0.75
RSI 54.59
Earnings Date May 14, 2025

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ... [Read more]

Sector Healthcare
Founded 1945
Employees 25,599
Stock Exchange London Stock Exchange
Ticker Symbol 0A0D
Full Company Profile

Financial Performance

In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.

Financial numbers in USD Financial Statements

News

There is no news available yet.